# The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal Time

> **NCT03209908** · — · UNKNOWN · sponsor: **Beijing Ditan Hospital** · enrollment: 380 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate

## Key facts

- **NCT ID:** NCT03209908
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03209908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03209908, "The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal Time". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03209908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*